This trial is active, not recruiting.

Condition osteoarthritis
Treatment latella knee implant system
Sponsor Cotera, Inc.
Start date November 2013
End date September 2015
Trial identifier NCT02002637, COT1-13-01, COTERA-1


The objective of this study is to evaluate the safety and technical feasibility of implanting the Latella Implant System in the treatment of patients with medial osteoarthritis of the knee.

United States No locations recruiting
Other countries No locations recruiting

Primary Outcomes

Freedom from unanticipated serious adverse device effects
time frame: 12 Months

Eligibility Criteria

All participants from 30 years up to 65 years old.

Inclusion Criteria: - History of pain as due to medial osteoarthritis Exclusion Criteria: - Rheumatoid arthritis - Joint or ligament instability - Metal ion allergy

Additional Information

Official title Evaluation of the Latella Implant System for Lateralization of the Iliotibial Band to Offload the Medial Condyle for Pain Relief in Patients With Medial Osteoarthritis - A Safety Study
Principal investigator Manoj Ramachandran, MD
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Cotera, Inc..